Medicinal Plants and Phytochemicals in Cardioprotection—Mechanistic Pathways and Translational Roadmap
Life · 21.01.2026 · 16 (1) · 175
DOI: 10.3390/life16010175 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 21.01.2026. Verfasst von Diana Maria Morariu-Briciu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Embryology, Faculty of Medicine, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 326 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Despite major advances in guideline-directed cardiovascular therapy, residual cardiovascular risk persists, partly driven by oxidative stress, chronic inflammation, endothelial dysfunction, and mitochondrial injury not fully addressed by current drugs. Translation of plant-based cardioprotectants is constrained by preparation-dependent variability in extract chemistry (plant part/cultivar/processing and extraction method), low and variable systemic exposure for key actives (notably curcuminoids and many polyphenols), and clinically relevant safety/interaction considerations (e.g., hepatotoxicity reports with concentrated green tea extracts and antiplatelet-related bleeding-risk considerations for some botanicals). We therefore provide a mechanism- and translation-oriented synthesis of evidence for cardioprotective botanicals, chosen for long-standing traditional use and scientific validation with reproducible experimental data and, where available, human studies, including Crataegus monogyna, Allium sativum, Olea europaea, Ginkgo biloba, Leonurus cardiaca, and Melissa officinalis. Across studies, polyphenols (especially flavonoids and phenolic acids) and organosulfur compounds are most consistently associated with cardioprotection, while terpene-derived constituents and secoiridoids contribute mechanistically in plant-specific settings (e.g., Ginkgo and Olea). Predominantly in experimental models, these agents engage redox-adaptive (Nrf2), mitochondrial (mPTP), endothelial, and inflammatory (NF-κB) pathways, with reported reductions in ischemia–reperfusion injury, oxidative damage, and apoptosis. Clinical evidence remains heterogeneous and is largely confined to short-term studies and surrogate outcomes (blood pressure, lipids, oxidative biomarkers, endothelial function), with scarce data on hard cardiovascular endpoints or event reduction. Priorities include standardized, chemotype-controlled formulations with PK/PD-guided dosing and adequately powered randomized trials that assess safety and herb–drug interactions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy and Embryology, Faculty of Medicine, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Doctoral School, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Department of Toxicology, Drug Industry, Marketing, Management, and Dermatopharmacy, Faculty of Pharmacy, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Research Center for Pharmaco-Toxicological Evaluations, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Cardiology Department, Faculty of Pharmacy, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Department of Surgery II, Faculty of Medicine, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
ORCID-Profile: Alex-Robert Jîjie, Sorin Dan Chiriac, Cătălin Prodan Bărbulescu
Zitieren
APA
Morariu-Briciu, D. M., Jîjie, A. R., Bolintineanu, S. L., Pah, A. M., Chiriac, S. D., Chevereșan, A., Dumitrașcu, V., Prodan Bărbulescu, C., & Jipa, R. (2026). Medicinal Plants and Phytochemicals in Cardioprotection—Mechanistic Pathways and Translational Roadmap. Life, 16(1), 175. https://doi.org/10.3390/life16010175
Vancouver
Morariu-Briciu DM, Jîjie AR, Bolintineanu SL, Pah AM, Chiriac SD, Chevereșan A, et al. Medicinal Plants and Phytochemicals in Cardioprotection—Mechanistic Pathways and Translational Roadmap. Life. 2026;16(1):175. doi:10.3390/life16010175
BibTeX
@article{MorariuBriciu2026,
author = {Morariu-Briciu, Diana Maria and Jîjie, Alex-Robert and Bolintineanu, Sorin Lucian and Pah, Ana-Maria and Chiriac, Sorin Dan and Chevereșan, Adelina and Dumitrașcu, Victor and Prodan Bărbulescu, Cătălin and Jipa, Radu},
title = {Medicinal Plants and Phytochemicals in Cardioprotection—Mechanistic Pathways and Translational Roadmap},
journal = {Life},
year = {2026},
volume = {16},
number = {1},
pages = {175},
doi = {10.3390/life16010175}
}
EUVIMED